Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.48 |
| ▸ | GSK3B | P49841 | 2/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.43 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.43 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | KIF11 | P52732 | 2/20 | 0.41 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.40 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.40 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.40 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1922803 | 0.79 | CYP1A2 (0.62) | CES1PTPN1CYP1A2ALDH1A1TSHR | |
| SCHEMBL71911 | 0.79 | CYP1A2 (0.62) | CES1PTPN1CYP1A2ALDH1A1TSHR | |
| SCHEMBL29614400 | 0.79 | CYP1A2 (0.62) | CES1PTPN1CYP1A2ALDH1A1TSHR | |
| SCHEMBL24244082 | 0.77 | CES2 (0.54) | CES2CES1SRD5A2GSK3BEPHX2 | |
| SCHEMBL3163440 | 0.77 | CYP2C9 (0.59) | CES2CES1SRD5A2GSK3BEPHX2 | |
| SCHEMBL23588301 | 0.75 | CES2 (0.56) | CES2CES1SRD5A2GSK3BEPHX2 | |
| SCHEMBL30434274 | 0.74 | CES2 (0.50) | CES2CES1SRD5A2GSK3BEPHX2 | |
| Bicarbonate SCHEMBL29616827 | 0.73 | CES2 (0.54) | CES2CES1SRD5A2GSK3BEPHX2 | |
| Bromomethane SCHEMBL3163413 | 0.72 | CYP2C9 (0.55) | CES2CES1SRD5A2GSK3BEPHX2 | |
| SCHEMBL28960373 | 0.72 | CYP2C9 (0.64) | CES2CES1SRD5A2EPHX2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080311636-A1 | Method for Producing Optically Active Alpha-Hydroxycarboxylic Acid | DAIICHI FINE CHEMICAL CO., LTD. (JP) | 2008-12-18 | — | — | US | disclosed |
| EP-1930441-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE -HYDROXYCARBOXYLIC ACID | Daiichi Fine Chemical Co., Ltd. (JP) | 2008-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311636-A1 | Method for Producing Optically Active Alpha-Hydroxycarboxylic Acid | PCCA, HCAR1, HCAR2 | CES2 481/4885CES1 189/4885SRD5A2 863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.